A Clinical Study to Compare the Efficacy and Safety of a Novel Medicine (NNC0268-0965) With Insulin Glargine

NCT04575181 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

86

Enrollment

INDUSTRY

Sponsor class

Conditions

Diabetes Mellitus, Type 2

Interventions

DRUG: NNC0268-0965
DRUG: Insulin glargine
DRUG: Placebo (NNC0268-0965)
DRUG: Placebo (insulin glargine)

Sponsor

Novo Nordisk A/S